Drug Targets in Infections with Ebola and Marburg Viruses Olinger G. Gene], Biggins E. Julia], Melanson R. Vanessa], Wahl-Jensen Victoria l , Geisbert W. Thomas2 and Hensley

Filovirus RefSeq Entries: Evaluation and Selection of Filovirus Type Variants, Type Sequences, and NamesFilovirus RefSeq Entries: Evaluation and Selection of Filovirus Type

Division of Infectious Disease Epidemiology, January 13, 2015 Page 1 Viral hemorrhagic fever (VHF) is a clinical illness associated with fever and bleeding diathesis caused

Possible Bioterrorism Agents (CDC classified A, B or C Agent) Viral Hemorrhagic Fever What is Viral Hemorrhagic Fever? Viral Hemorrhagic Fever (VHF) disease is caused by

CDC Fact SheetNational Center for Emerging and Zoonotic Infectious Diseases Division of High-Consequence Pathogens and Pathology (DHCPP) Ebola hemorrhagic fever (Ebola HF)

Guidelines for Healthcare Professionals Guidelines for Healthcare Professionals, July 2019 – V.1.01 Contents 1. INTRODUCTION 4 2. CASE DEFINITION 6 Patient Placement

Reporting Obligations REPORTING FORM Additional Resources References 1. Ministry of Health and Long Term Care, Infectious Diseases Protocol, 2014. 1. PHO. “Ebola virus

Viral Hemorrhagic Fever: Guidance for Healthcare Providers Page 1 of 13 VDH/OEPI/DSI Revised February 2019 Virginia Department of Health Viral Hemorrhagic Fever: Guidance

Research.qxdWe conducted two antibody surveys to assess risk fac- tors for Marburg hemorrhagic fever in an area of confirmed Marburg virus transmission in the Democratic

Antigenicity and Vaccine Potential of Marburg Virus Glycoprotein Expressed by Baculovirus RecombinantsAntigenicity and Vaccine Potential of Marburg Virus Glycoprotein Expressed